{"title":"更正“美国糖尿病患者的处方药支出:2012-2021”。","authors":"","doi":"10.1111/1753-0407.70158","DOIUrl":null,"url":null,"abstract":"<p>S. Li, S. Pan, N. Xiao, S. Jiang, G. G. Liu, and B. Lyu, “Prescription Medication Expenditures for Patients With Diabetes in the United States: 2012–2021,” <i>Journal of Diabetes</i> 17, no. 7 (2025): e70106, https://doi.org/10.1111/1753-0407.70106.</p><p>In the published version of the article, Figure 2 in the main text was incorrectly linked to Figure S4 (Supporting Information). The correct Figure 2 should correspond to the Graphical Abstract Image, as intended and originally submitted.</p><p>We apologize for this error.</p>","PeriodicalId":189,"journal":{"name":"Journal of Diabetes","volume":"17 10","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12504908/pdf/","citationCount":"0","resultStr":"{\"title\":\"Correction to “Prescription Medication Expenditures for Patients With Diabetes in the United States: 2012–2021”\",\"authors\":\"\",\"doi\":\"10.1111/1753-0407.70158\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>S. Li, S. Pan, N. Xiao, S. Jiang, G. G. Liu, and B. Lyu, “Prescription Medication Expenditures for Patients With Diabetes in the United States: 2012–2021,” <i>Journal of Diabetes</i> 17, no. 7 (2025): e70106, https://doi.org/10.1111/1753-0407.70106.</p><p>In the published version of the article, Figure 2 in the main text was incorrectly linked to Figure S4 (Supporting Information). The correct Figure 2 should correspond to the Graphical Abstract Image, as intended and originally submitted.</p><p>We apologize for this error.</p>\",\"PeriodicalId\":189,\"journal\":{\"name\":\"Journal of Diabetes\",\"volume\":\"17 10\",\"pages\":\"\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-10-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12504908/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Diabetes\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/1753-0407.70158\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Diabetes","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1753-0407.70158","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
Correction to “Prescription Medication Expenditures for Patients With Diabetes in the United States: 2012–2021”
S. Li, S. Pan, N. Xiao, S. Jiang, G. G. Liu, and B. Lyu, “Prescription Medication Expenditures for Patients With Diabetes in the United States: 2012–2021,” Journal of Diabetes 17, no. 7 (2025): e70106, https://doi.org/10.1111/1753-0407.70106.
In the published version of the article, Figure 2 in the main text was incorrectly linked to Figure S4 (Supporting Information). The correct Figure 2 should correspond to the Graphical Abstract Image, as intended and originally submitted.
期刊介绍:
Journal of Diabetes (JDB) devotes itself to diabetes research, therapeutics, and education. It aims to involve researchers and practitioners in a dialogue between East and West via all aspects of epidemiology, etiology, pathogenesis, management, complications and prevention of diabetes, including the molecular, biochemical, and physiological aspects of diabetes. The Editorial team is international with a unique mix of Asian and Western participation.
The Editors welcome submissions in form of original research articles, images, novel case reports and correspondence, and will solicit reviews, point-counterpoint, commentaries, editorials, news highlights, and educational content.